Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

被引:430
|
作者
Dinulescu D.M. [1 ,2 ]
Ince T.A. [3 ,4 ]
Quade B.J. [4 ]
Shafer S.A. [1 ,2 ]
Crowley D. [1 ,2 ]
Jacks T. [1 ,2 ]
机构
[1] Center for Cancer Research, MA Institute of Technology, Cambridge, MA 02139
[2] Department of Biology, MA Institute of Technology, Cambridge, MA 02139
[3] Whitehead Institute, Nine Cambridge Center, Cambridge
[4] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
关键词
D O I
10.1038/nm1173
中图分类号
学科分类号
摘要
Epithelial ovarian tumors present a complex clinical, diagnostic and therapeutic challenge because of the difficulty of early detection, lack of known precursor lesions and high mortality rates. Endometrioid ovarian carcinomas are frequently associated with endometriosis, but the mechanism for this association remains unknown. Here we present the first genetic models of peritoneal endometriosis and endometrioid ovarian adenocarcinoma in mice, both based on the activation of an oncogenic K-ras allele. In addition, we find that expression of oncogenic K-ras or conditional Pten deletion within the ovarian surface epithelium gives rise to preneoplastic ovarian lesions with an endometrioid glandular morphology. Furthermore, the combination of the two mutations in the ovary leads to the induction of invasive and widely metastatic endometrioid ovarian adenocarcinomas with complete penetrance and a disease latency of only 7 weeks. The ovarian cancer model described in this study recapitulates the specific tumor histomorphology and metastatic potential of the human disease.
引用
收藏
页码:63 / 70
页数:7
相关论文
共 50 条
  • [1] K-ras is essential for the development of the mouse embryo
    Koera, K
    Nakamura, K
    Nakao, K
    Miyoshi, J
    Toyoshima, K
    Hatta, T
    Otani, H
    Aiba, A
    Katsuki, M
    ONCOGENE, 1997, 15 (10) : 1151 - 1159
  • [2] K-Ras is essential for the development of the mouse embryo
    Keiko Koera
    Kenji Nakamura
    Kazuki Nakao
    Jun Miyoshi
    Kumao Toyoshima
    Toshihisa Hatta
    Hiroki Otani
    Atsu Aiba
    Motoya Katsuki
    Oncogene, 1997, 15 : 1151 - 1159
  • [3] Murine models of colorectal cancer:: studying the role of oncogenic K-ras
    Janssen, KP
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (03) : 495 - 506
  • [4] Murine models of colorectal cancer: studying the role of oncogenic K-ras
    K.-P. Janssen
    Cellular and Molecular Life Sciences CMLS, 2003, 60 : 495 - 506
  • [5] The modulation of adaptive immune response by oncogene K-ras; mouse model of ovarian cancer
    Takahashi, Juri
    Kawana, Kei
    Taguchi, Ayumi
    Yoshida, Mitsuyo
    Nakamura, Hiroe
    Fujimoto, Asaha
    Sato, Masakazu
    Inoue, Tomoko
    Adachi, Katsuyuki
    Nagasaka, Kazunori
    Oda, Katsutoshi
    Osuga, Yutaka
    Fujii, Tomoyuki
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2015, 112 : 132 - 132
  • [6] Biochip for K-ras mutation screening in ovarian cancer
    Fabjani, G
    Kriegshaeuser, G
    Schuetz, A
    Prix, L
    Zeillinger, R
    CLINICAL CHEMISTRY, 2005, 51 (04) : 784 - 787
  • [7] K-Ras role in lung cancer therapy
    Zhang, Z.
    Wang, Zhou
    MINERVA CHIRURGICA, 2011, 66 (03) : 251 - 268
  • [8] While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable
    Plowman, SJ
    Williamson, DJ
    O'Sullivan, MJ
    Doig, J
    Ritchie, AM
    Harrison, DJ
    Melton, DW
    Arends, MJ
    Hooper, ML
    Patek, CE
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (24) : 9245 - 9250
  • [9] A biochip for rapid K-ras mutation screening in ovarian cancer.
    Zeillinger, R
    Fabjani, G
    Kriegshaeuser, G
    Schuetz, A
    Prix, L
    CLINICAL CHEMISTRY, 2004, 50 (11) : 2229 - 2229
  • [10] K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma
    Otsuka J.
    Okuda T.
    Sekizawa A.
    Amemiya S.
    Saito H.
    Okai T.
    Kushima M.
    Tachikawa T.
    Medical Electron Microscopy, 2004, 37 (3): : 188 - 192